Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19. Chandra, A., Gurjar, V., Qamar, I., & Singh, N. Journal of Biomolecular Structure and Dynamics, 39(12):4201-4211, Taylor and Francis Ltd., 2021.
Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19 [link]Paper  doi  bibtex   
@ARTICLE{Chandra20214201,
author={Chandra, A. and Gurjar, V. and Qamar, I. and Singh, N.},
title={Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19},
journal={Journal of Biomolecular Structure and Dynamics},
year={2021},
volume={39},
number={12},
pages={4201-4211},
doi={10.1080/07391102.2020.1775127},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087029269&doi=10.1080%2f07391102.2020.1775127&partnerID=40&md5=02e43eec39db30c92a005b2b9da646ab},
publisher={Taylor and Francis Ltd.},
issn={07391102},
coden={JBSDD},
abbrev_source_title={J. Biomol. Struct. Dyn.},
}

Downloads: 0